None
EN
Oric Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
["Investor'S Business Daily"]
Investor's Business Daily
The Relative Strength (RS) Rating for Oric Pharmaceuticals (ORIC) entered a new percentile Monday, with an increase from 79 to 84.
Looking For The Best Stocks To Buy And Watch?
Start Here This proprietary rating identifies market leadership by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our…